Muscle Atrophy Clinical Trials

Find Muscle Atrophy Clinical Trials Near You

Blood Flow Restriction Training in Acute Geriatric Rehabilitation: A Randomized Controlled Trial on Its Effects and Safety in Hospitalized Older Adults.

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Background: Older adults have a reduced ability to build and maintain muscle mass due to age-related changes in the muscular system. The resulting sarcopenia can lead to a number of health problems and limitations, such as an increased risk of falling and reduced mobility, which can affect quality of life and increase the risk of disease. To increase muscle mass and strength, high-intensity resistance training with loads of 70 to 85% of the repetition maximum (1RM) is recommended. However, this type of training poses a major challenge in the rehabilitation sector, as there is also an increased risk of injury due to physical limitations in old age. According to current research, low-intensity occlusion training could therefore represent a safe and effective training alternative. The aim of this study is therefore to examine the feasibility and effects of blood flow restriction training (BFR) on general health in older adults in a rehabilitative setting.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

• Adults \>65 years with a two week hospitalized acute rehabilitation after a fracture closed to the hip joint

Locations
Other Locations
Germany
St. Marien-Hospital Köln
RECRUITING
Cologne
Contact Information
Primary
Alexander Franz, Dr. med., B.Sc.
alexander.franz@ukbonn.de
+491703750718
Time Frame
Start Date: 2026-01-01
Estimated Completion Date: 2027-03-31
Participants
Target number of participants: 60
Treatments
Experimental: Intervention Group
Blood-Flow-Restriction Training
Active_comparator: Control Group
Sham-Blood-Flow-Restriction Training
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Bonn

This content was sourced from clinicaltrials.gov